MTWA technology is available on a number of platforms including the CH2000 and HearTwave II cardiac diagnostic systems.
The CH2000 and HearTwave II systems are dual-use products, featuring state-of-the-art stress testing capability in addition to MTWA testing.
Microvolt T-Wave Alternans™ enhances stress testing by incorporating a non-invasive, clinically-proven, reimbursable test that can help identify patients at risk for Sudden Cardiac Arrest (SCA). Cambridge Heart’s test is the only Medicare-reimbursable MTWA option.
Cambridge Heart’s MTWA technology is also available on the Q-Stress system by Cardiac Science.